CoChat

Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial

Open access
Vanderheyden, Simon, Casaer, Michael P, Kesteloot, Katrien, Simoens, Steven, De Rijdt, Thomas, Peers, Guido, Wouters, Pieter J, Coenegrachts, Jocelijn, Grieten, Tine, Polders, Katleen, Maes, Ann, Wilmer, Alexander, Dubois, Jasperina, Van den Berghe, Greet, Mesotten, Dieter · 2012 · Critical Care
Cited by 70

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Introduction: The EPaNIC randomized controlled multicentre trial showed that postponing initiation of parenteral nutrition (PN) in ICU-patients to beyond the first week (Late-PN) enhanced recovery, as compared with Early-PN. This was mediated by fewer infections, accelerated recovery from organ failure and reduced duration of hospitalization. Now, the trial's preplanned cost analysis (N = 4640) from the Belgian healthcare payers' perspective is reported. Methods: Cost data were retrieved from individual patient invoices. Undiscounted total healthcare costs were calculated for the index hospital stay. A cost tree based on acquisition of new infections and on prolonged length-of-stay was constructed. Contribution of 8 cost categories to total hospitalization costs was analyzed. The origin of drug costs was clarified in detail through the Anatomical Therapeutic Chemical (ATC) classification system. The potential impact of Early-PN on total hospitalization costs in other healthcare systems was explored in a sensitivity analysis. Results: ICU-patients developing new infection (24.4%) were responsible for 42.7% of total costs, while ICU-patients staying beyond one week (24.3%) accounted for 43.3% of total costs. Pharmacy-related costs represented 30% of total hospitalization costs and were increased by Early-PN (+608.00 EUR/patient, p = 0.01). Notably, costs for ATC-J (anti-infective agents) (+227.00 EUR/patient, p = 0.02) and ATC-B (comprising PN) (+220.00 EUR/patient, p = 0.006) drugs were increased by Early-PN. Sensitivity analysis revealed a mean total cost increase of 1,210.00 EUR/patient (p = 0.02) by Early-PN, when incorporating the full PN costs. Conclusions: The increased costs by Early-PN were mainly pharmacy-related and explained by higher expenditures for PN and anti-infective agents. The use of Early-PN in critically ill patients can thus not be recommended for both clinical (no benefit) and cost-related reasons. Trial registration: ClinicalTrials.gov NCT00512122 .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/cc11361

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 70

Metadata

Authors
Vanderheyden, S., Casaer, M. P., Kesteloot, K., Simoens, S., De Rijdt, T., Peers, G., Wouters, P. J., Coenegrachts, J., Grieten, T., Polders, K., Maes, A., Wilmer, A., Dubois, J., Van den Berghe, G., & Mesotten, D.
Venue
Critical Care
Published
2012-05-25
Volume
16
Issue
3
Pages
R96-R96
ISSN
1364-8535 (ISSN-L)
OpenAlex
W2100566529
Cited by
70
References
6
FWCI
7.63
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial. https://app.cochat.ai/papers/10.1186/cc11361
The paper
Vanderheyden, S., Casaer, M. P., Kesteloot, K., Simoens, S., De Rijdt, T., Peers, G., Wouters, P. J., Coenegrachts, J., Grieten, T., Polders, K., Maes, A., Wilmer, A., Dubois, J., Van den Berghe, G., & Mesotten, D. (2012). Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial. Critical Care. https://doi.org/10.1186/cc11361

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.